MAPT and Alzheimer disease: In a larger cohort of patients with a clinical diagnosis of AD, the patients showing a LATE-NC–like FDG-PET pattern were significantly older, exhibited a predominant amnestic phenotype, had a slower disease course, and showed less abnormal amyloid and tau CSF biomarkers as well as lower prevalence of APOE ε4 allele [86].